01- ISCHEMIA: Prognosis is Determined by Anatomy, not Functionality
The ISCHEMIA study keeps providing scientific news. This work in patients with stable coronary artery disease had already shown (to our surprise) that ischemic burden does not predict 4-year mortality.
Read also HERE
02- Chile Sessions 2021 | Clinical Case Contest for Young Interventionists
It is with great pleasure that we hereby invite all young Latin American cardiologists to submit relevant clinical cases related to interventional cardiology for the upcoming SOLACI Sessions, Chile 2021, to be held on Nov 27, 2021.
Read also HERE
03- Hypertensive Patients: Maximizing Doses or Adding New Drugs
Adding new medication in moderate doses to control hypertension conveniently maximizes efficacy, reduces adverse effects and minimizes costs, among other advantages. On the flipside, patients having to remember a whole list of drugs and their combination will often lead to non-adherence or forgetfulness. The latter has been shown not only by dedicated trials, but also by studies on renal denervation.
Read also HERE
04- Failed Aortic Bioprosthesis: Valve in Vale or Repeat Surgery?
The Valve in Valve (ViV) technique seems to be a better option than repeat surgery for failed aortic bioprosthesis. While this strategy lacks long-term evidence to address issues such as durability, it is considered as an option especially for young patients.
Read also HERE
05- Drug-Eluting Balloons Find Their Niche
According to this large European registry, drug-eluting balloons (DEBs) are competing with drug-eluting stents (DES) to treat in-stent restenosis. Drug-eluting balloons seem to work equally well for the treatment of long-term in-stent restenosis compared with new stent implantation (for the thin-strut DES registry).
Read also HERE
06- More Screening Needed Before Non-Cardiac Surgery
According to this recent document by the American Heart Association (AHA), troponin should be monitored for at least 3 days after surgery.
Read also HERE
07- More Keys to Define Moderate Aortic Stenosis
Amidst the current efforts to prove early intervention might have benefits in moderate aortic stenosis (AS), this trial comes along directing us back to basics.
Read also HERE
08- 10 Years Treating Bifurcations: Have We Made Progress?
Bifurcations have been, are and will be challenging. However, we have to admit we have gained experience and have more tools than pioneer interventionists and many of the early experts who have made history.
Read also HERE
09- Are Antithrombotics Necessary in Outpatients after COVID-19?
According to this recent study (soon to be published in JAMA), antithrombotic therapy has no clinical benefits for outpatients with stable symptoms of COVID-19.
Read also HERE
Subscribe to our weekly newsletter
Get the latest scientific articles on interventional cardiology
